Gastrointestinal Cancer Center, Ordensklinikum Linz, Seilerstaette 4, 4010, Linz, Austria.
Medical Faculty, Johannes Kepler University, Linz, Austria.
J Cancer Res Clin Oncol. 2022 Nov;148(11):3007-3014. doi: 10.1007/s00432-021-03868-0. Epub 2022 Jan 3.
Incidence and mortality of colorectal cancer (CRC) declined over the last decades. However, survival depends on the primary tumor location. It is unknown if all progress in outcomes vary depending on left-sided (LCRC) versus right-sided (RCC) colorectal cancer. We compare incidence and mortality rates over time according to the primary tumor location.
Data from the Austrian National Cancer Registry spanning from 1983 to 2018 were used to calculate annual incidence and mortality rates and survival stratified by primary tumor localization and stage. Joinpoint regression with linear regression models were used on different subgroups to identify significant changes of incidence- and mortality slopes.
A total of 168,260 (incidence dataset) and 87,355 cases (mortality dataset) were identified. Survival of disseminated RCC was worse compared to LCRC (HR 1.14; CI 1.106-1.169). Total and LCRC incidence and mortality rates declined steadily over time, whereas the rates of RCC did not. Incidence of disseminated RCC declined significantly less (slope - 0.07; CI - 0.086; - 0.055) than in LCRC (slope - 0.159; CI - 0.183; - 0.136); mortality rate of RCC was unchanged over time. Incidence and mortality of localized RCC remained unchanged over time, whereas both rates declined independently of stage in LCRC.
Colorectal cancer outcomes during the last 35 years have preferentially improved in LCRC but not in RCC, indicating that the progress made is limited to LCRC. It is necessary to define RCC as a distinct form of CRC and to focus on specific strategies for its early detection and treatment.
在过去几十年中,结直肠癌(CRC)的发病率和死亡率有所下降。然而,生存取决于原发肿瘤的位置。目前尚不清楚所有在结局方面取得的进展是否因左半结直肠癌(LCRC)与右半结直肠癌(RCC)而有所不同。我们根据原发肿瘤位置比较了随时间推移的发病率和死亡率。
使用 1983 年至 2018 年期间的奥地利国家癌症登记处的数据,计算按原发肿瘤定位和分期分层的年度发病率和死亡率以及生存率。使用线性回归模型对不同亚组进行 Joinpoint 回归,以确定发病率和死亡率斜率的显著变化。
共确定了 168260 例(发病率数据集)和 87355 例(死亡率数据集)病例。转移性 RCC 的总生存情况比 LCRC 差(HR 1.14;95%CI 1.106-1.169)。总的和 LCRC 的发病率和死亡率随时间稳步下降,而 RCC 的发病率则没有。转移性 RCC 的发病率显著下降(斜率-0.07;95%CI-0.086;-0.055),低于 LCRC(斜率-0.159;95%CI-0.183;-0.136);RCC 的死亡率随时间不变。局部 RCC 的发病率和死亡率随时间保持不变,而在 LCRC 中,这两个比率均独立于分期而下降。
在过去的 35 年中,LCRC 的结直肠癌结局得到了改善,但 RCC 没有,这表明所取得的进展仅限于 LCRC。有必要将 RCC 定义为一种独特的 CRC 形式,并专注于针对其早期检测和治疗的特定策略。